These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21388136)

  • 21. Autochelation in dipeptide boronic acids: pH-dependent structures and equilibria of Asp-boroPro and His-boroPro by NMR spectroscopy.
    Sudmeier JL; Zhou Y; Lai JH; Maw HH; Wu W; Bachovchin WW
    J Am Chem Soc; 2005 Jun; 127(22):8112-9. PubMed ID: 15926838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries.
    Matheeussen V; Baerts L; De Meyer G; De Keulenaer G; Van der Veken P; Augustyns K; Dubois V; Scharpé S; De Meester I
    Biol Chem; 2011 Mar; 392(3):189-98. PubMed ID: 21194356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic analysis of a dipeptide library for inhibitor development using human dipeptidyl peptidase IV produced by a Saccharomyces cerevisiae expression system.
    Hikida A; Ito K; Motoyama T; Kato R; Kawarasaki Y
    Biochem Biophys Res Commun; 2013 Jan; 430(4):1217-22. PubMed ID: 23268343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of selective and potent inhibitors of fibroblast activation protein and prolyl oligopeptidase.
    Poplawski SE; Lai JH; Li Y; Jin Z; Liu Y; Wu W; Wu Y; Zhou Y; Sudmeier JL; Sanford DG; Bachovchin WW
    J Med Chem; 2013 May; 56(9):3467-77. PubMed ID: 23594271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and structure-activity relationship of N-acyl-Gly-, N-acyl-Sar- and N-blocked-boroPro inhibitors of FAP, DPP4, and POP.
    Tran T; Quan C; Edosada CY; Mayeda M; Wiesmann C; Sutherlin D; Wolf BB
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1438-42. PubMed ID: 17174090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and characterization of constrained peptidomimetic dipeptidyl peptidase IV inhibitors: amino-lactam boroalanines.
    Lai JH; Wu W; Zhou Y; Maw HH; Liu Y; Milo LJ; Poplawski SE; Henry GD; Sudmeier JL; Sanford DG; Bachovchin WW
    J Med Chem; 2007 May; 50(10):2391-8. PubMed ID: 17458948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human serum dipeptidyl peptidase IV (DPPIV) and its unique properties.
    Shibuya-Saruta H; Kasahara Y; Hashimoto Y
    J Clin Lab Anal; 1996; 10(6):435-40. PubMed ID: 8951616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A high-throughput, multiplexed assay for superfamily-wide profiling of enzyme activity.
    Bachovchin DA; Koblan LW; Wu W; Liu Y; Li Y; Zhao P; Woznica I; Shu Y; Lai JH; Poplawski SE; Kiritsy CP; Healey SE; DiMare M; Sanford DG; Munford RS; Bachovchin WW; Golub TR
    Nat Chem Biol; 2014 Aug; 10(8):656-63. PubMed ID: 24997602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic potential of boron-containing compounds.
    Baker SJ; Ding CZ; Akama T; Zhang YK; Hernandez V; Xia Y
    Future Med Chem; 2009 Oct; 1(7):1275-88. PubMed ID: 21426103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dipeptidyl peptidase IV inhibition downregulates Na+ - H+ exchanger NHE3 in rat renal proximal tubule.
    Girardi AC; Fukuda LE; Rossoni LV; Malnic G; Rebouças NA
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F414-22. PubMed ID: 18077600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dipeptidyl peptidase IV: development, design, synthesis and biological evaluation of inhibitors.
    Borloo M; De Meester I
    Verh K Acad Geneeskd Belg; 1994; 56(1):57-88. PubMed ID: 7911611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition.
    Kirby M; Yu DM; O'Connor S; Gorrell MD
    Clin Sci (Lond); 2009 Sep; 118(1):31-41. PubMed ID: 19780719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of divalent cations on the porcine kidney cortex membrane-bound form of dipeptidyl peptidase IV.
    Pascual I; Gómez H; Pons T; Chappé M; Vargas MA; Valdés G; Lopéz A; Saroyán A; Charli JL; de los Angeles Chávez M
    Int J Biochem Cell Biol; 2011 Mar; 43(3):363-71. PubMed ID: 21093607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of highly potent amidine containing inhibitors of serine proteases and their N-hydroxylated prodrugs (amidoximes).
    Kotthaus J; Steinmetzer T; van de Locht A; Clement B
    J Enzyme Inhib Med Chem; 2011 Feb; 26(1):115-22. PubMed ID: 20583861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity relationship of boronic acid derivatives of tyropeptin: proteasome inhibitors.
    Watanabe T; Abe H; Momose I; Takahashi Y; Ikeda D; Akamatsu Y
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5839-42. PubMed ID: 20727746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide truncation by dipeptidyl peptidase IV: a new pathway for drug discovery?
    Scharpé S; De Meester I
    Verh K Acad Geneeskd Belg; 2001; 63(1):5-32; discussion 32-3. PubMed ID: 11284388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of dipeptidyl peptidase IV in an in vivo immune response.
    Kubota T; Flentke GR; Bachovchin WW; Stollar BD
    Clin Exp Immunol; 1992 Aug; 89(2):192-7. PubMed ID: 1353423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of 3-pyridylacetamide derivatives as dipeptidyl peptidase IV (DPP-4) inhibitors targeting a bidentate interaction with Arg125.
    Miyamoto Y; Banno Y; Yamashita T; Fujimoto T; Oi S; Moritoh Y; Asakawa T; Kataoka O; Takeuchi K; Suzuki N; Ikedo K; Kosaka T; Tsubotani S; Tani A; Funami M; Amano M; Yamamoto Y; Aertgeerts K; Yano J; Maezaki H
    Bioorg Med Chem; 2011 Jan; 19(1):172-85. PubMed ID: 21163664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovery, viscoelastic and functional properties of Barbel skin gelatine: investigation of anti-DPP-IV and anti-prolyl endopeptidase activities of generated gelatine polypeptides.
    Sila A; Martinez-Alvarez O; Haddar A; Gómez-Guillén MC; Nasri M; Montero MP; Bougatef A
    Food Chem; 2015 Feb; 168():478-86. PubMed ID: 25172738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, biological evaluation, and structure-activity relationship (SAR) discussion of dipeptidyl boronate proteasome inhibitors, part I: comprehensive understanding of the SAR of alpha-amino acid boronates.
    Zhu Y; Zhao X; Zhu X; Wu G; Li Y; Ma Y; Yuan Y; Yang J; Hu Y; Ai L; Gao Q
    J Med Chem; 2009 Jul; 52(14):4192-9. PubMed ID: 19537716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.